KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Change in Receivables (2020 - 2026)

AbCellera Biologics filings provide 7 years of Change in Receivables readings, the most recent being -$13.1 million for Q1 2026.

  • Quarterly Change in Receivables fell 1256.49% to -$13.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $41.4 million through Mar 2026, down 28.24% year-over-year, with the annual reading at $55.6 million for FY2025, 25.95% down from the prior year.
  • Change in Receivables hit -$13.1 million in Q1 2026 for AbCellera Biologics, down from $39.7 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $39.7 million in Q4 2025 and bottomed at -$13.1 million in Q1 2026.
  • Average Change in Receivables over 5 years is $11.0 million, with a median of $11.2 million recorded in 2023.
  • The largest annual shift saw Change in Receivables surged 1900.0% in 2023 before it crashed 1256.49% in 2026.
  • AbCellera Biologics' Change in Receivables stood at $19.0 million in 2022, then tumbled by 45.18% to $10.4 million in 2023, then soared by 99.86% to $20.9 million in 2024, then skyrocketed by 90.14% to $39.7 million in 2025, then tumbled by 133.03% to -$13.1 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Change in Receivables are -$13.1 million (Q1 2026), $39.7 million (Q4 2025), and $3.4 million (Q3 2025).